Home > Insider Trading > Filing (0000904454-11-000504)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
932372	Orange 21 Inc.	ORNG	Ophthalmic Goods (3851)	330580186

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1071036	W Seth Hamot	420 Boylston Street Boston MA 02116	Yes	No	Yes	No
1319943	Roark, Rearden & Hamot Llc	420 Boylston Street Boston MA 02116	No	No	Yes	No
1319959	Costa Brava Partnership Iii Lp	222 Berkeley Street 17Th Floor Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-29	7,122	$1.72	6,182,903	No	4	P	Direct
Common Stock	Acquisiton	2011-08-30	500	$1.80	6,183,403	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The securities reported as directly beneficially owned by Costa Brava Partnership III L.P. may be deemed to be indirectly beneficially owned by Roark, Rearden & Hamot, LLC and Seth W. Hamot. Seth W. Hamot is the President and sole member of Roark, Rearden & Hamot, LLC, which is the sole general partner of Costa Brava Partnership III L.P. Pursuant to Instruction 4(b)(iv) of Form 4, Roark, Rearden & Hamot, LLC and Seth W. Hamot have elected to report as indirectly beneficially owned the entire number of securities owned by such limited partnership, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed its or his pecuniary interest therein and/or that are not actually distributed to it or him.
Seth W. Hamot, who is a Director of the Issuer, also directly beneficially owns 32,918 shares of Common Stock and indirectly beneficially owns an aggregate 6,000 shares of Common Stock held in two trusts for the benefit of his children.